# Evaluation of Safety and Efficacy of Remifentanil in Pediatric Population

> **NCT01477892** · PHASE1,PHASE2 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 14 (actual)

## Conditions studied

- Infant, Preterm

## Interventions

- **DRUG:** low dose remifentanil

## Key facts

- **NCT ID:** NCT01477892
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2013-09-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01477892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01477892, "Evaluation of Safety and Efficacy of Remifentanil in Pediatric Population". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01477892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*